Leucine-rich repeat kinase 2 impairs the release sites of Parkinson’s disease vulnerable dopamine axons
DOI:
10.48324/dandi.001933/0.260825.1457
10.48324/dandi.001933/0.260825.1457
ID: 001933
0.260825.1457
0.260825.1457
Contact He, Qianzi
File Count 27
Size 571.9 MB
Created August 25, 2026
Last update August 25, 2026
Licenses: spdx:CC-BY-4.0
Access Information: dandi:OpenAccess (embargoed until August 20, 2026)
Parkinson’s disease (PD) is defined pathologically by loss of dopamine-producing neurons in the substantia nigra pars compacta (SNc). Yet synaptic dysfunction emerges much earlier, making it essential to define the mechanisms that drive early nigrostriatal deregulation. In the SNc, molecularly distinct dopamine neuron subtypes show differential susceptibility to PD. In vivo fiber photometry of...
Keywords:
fiber photometry
dopamine
GRAB-DA
optogenetics
ChRmine
Parkinson's disease
substantia nigra
striatum
dopamine subtype
Subject matter:
dorsal striatum
substantia nigra
Parkinson's disease
substantia nigra pars compacta
striatum
dopaminergic neuron
Contributors
Nasios, Christopher
Funding information
Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network
- Award Number: ASAP-020600
Michael J. Fox Foundation for Parkinson's Research
- Award Number: ASAP-000463
Medical Research Council
- Award Number: MC_UU_00018/1
Research Ireland
- Award Number: 20/FFP-A/8446
National Institute of Neurological Disorders and Stroke
- Award Number: R01NS119690
National Cancer Institute
- Award Number: CA060553
National Institutes of Health
- Award Number: 1S10OD016342-01
National Institutes of Health
- Award Number: 1S10OD032270-01
Related resources